Taki Chemical Co., Ltd. carries a market capitalization of 40.82B, placing it among publicly traded companies globally. Its enterprise value stands at 34.80B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 40.82B |
| Enterprise Value | 34.80B |
Taki Chemical Co., Ltd. currently has 8.48M shares outstanding.
| Shares Outstanding | 8.48M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Taki Chemical Co., Ltd. trades at a trailing price-to-earnings ratio of 21.36. The price-to-sales ratio is 1.02, and the price-to-book ratio stands at 1.29.
| PE Ratio | 21.36 |
| PS Ratio | 1.02 |
| PB Ratio | 1.29 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Taki Chemical Co., Ltd. trades at an EV/EBITDA multiple of 22.39 and an EV/FCF ratio of 4,045.85. The EV/Sales ratio of 0.95 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 22.39 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.95 |
| EV / EBITDA | 22.39 |
| EV / EBIT | 22.39 |
| EV / FCF | 4,045.85 |
Taki Chemical Co., Ltd. maintains a current ratio of 2.72, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.84, indicating elevated leverage, while an interest coverage ratio of 129.50 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.72 |
| Quick Ratio | 0.43 |
| Debt / Equity | 2.84 |
| Debt / EBITDA | 0.68 |
| Interest Coverage | 129.50 |
Taki Chemical Co., Ltd. posts a return on equity of 6.16 and a return on invested capital of 3.02.
| Return on Equity (ROE) | 6.16 |
| Return on Assets (ROA) | 3.28 |
| Return on Invested Capital (ROIC) | 3.02 |
| Return on Capital Employed (ROCE) | 5.96 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.46 |
Over the trailing twelve months, Taki Chemical Co., Ltd. has paid 692.00M in income taxes, reflecting an effective tax rate of 28.33.
| Income Tax | 692.00M |
| Effective Tax Rate | 28.33 |
Taki Chemical Co., Ltd.'s stock has gained approximately 72.60854% over the past 52 weeks. The 50-day moving average sits at 4,976.20, while the 200-day moving average is 4,202.95.
| Beta (5Y) | N/A |
| 52-Week Price Change | 72.60854% |
| 50-Day Moving Average | 4,976.20 |
| 200-Day Moving Average | 4,202.95 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Taki Chemical Co., Ltd. generated 36.82B in revenue and converted that into 1.76B in net income, yielding earnings per share of 206.82. EBITDA reached 1.55B, while operating income came in at 1.55B.
| Revenue | 36.82B |
| Gross Profit | 7.76B |
| Operating Income | 1.55B |
| Pretax Income | 2.44B |
| Net Income | 1.76B |
| EBITDA | 1.55B |
| EBIT | 1.55B |
| Earnings Per Share (EPS) | 206.82 |
Taki Chemical Co., Ltd. holds 3.83B in cash and equivalents against 1.05B in total debt, resulting in a net debt position of -3.04B. Total book value stands at 29.17B, with working capital of 15.32B providing operational flexibility.
| Cash & Cash Equivalents | 3.83B |
| Total Debt | 1.05B |
| Net Debt | -3.04B |
| Equity (Book Value) | 29.17B |
| Book Value Per Share | 3,445.85 |
| Working Capital | 15.32B |
Taki Chemical Co., Ltd. operates with a gross margin of 21.06, reflecting its pricing power and cost economics. The operating margin of 4.22 and net profit margin of 4.77 provide insight into operational efficiency.
| Gross Margin | 21.06 |
| Operating Margin | 4.22 |
| Pretax Margin | 6.63 |
| Profit Margin | 4.77 |
| EBITDA Margin | 4.22 |
Taki Chemical Co., Ltd.'s most recent stock split took place on December 26, 2018 with a 1:2 split ratio.
| Last Split Date | 12/26/2018 |
| Split Ratio | 1:2 |
Taki Chemical Co., Ltd. posts an Altman Z-Score of 2.96, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.96 |